Company statement
In December 2024 the U.S. Food and Drug Administration sent Swiss Chems a warning letter. It concerned the marketing language used to describe two products — Semaglutide and Retatrutide — and nothing else. It did not allege that our compounds were impure, contaminated, mislabeled for potency, or unsafe to handle in a laboratory. It did not concern our SARMs, peptides, nootropics, bioregulators or PCT compounds.
We removed both products, rewrote our product descriptions, and tightened how we talk about everything we sell. Swiss Chems is open, shipping, and operating today at SwissChemzLab.com.
The rest of this page explains what happened in plain language, because a lot of what has been written about it since is guesswork.
What the letter actually said
The letter is dated 10 December 2024. It is a public document, so you do not have to take our summary for it.
Read the original: FDA Warning Letter to Swisschems, 10 December 2024The FDA’s argument was not that Semaglutide and Retatrutide were bad products. It was that the way we described them turned them into drugs in the eyes of the law.
Under section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act, what makes something a “drug” is its intended use — and intended use is established by what the seller says about it. Our product pages cited peer-reviewed studies on weight and glucose regulation. Our social media posts described one compound as a promising anti-obesity agent. The FDA’s position was that a “research use only” label at the bottom of a page does not cancel out claims like those at the top of it.
Once a product is a drug and has not been approved, selling it across state lines violates sections 505(a) and 301(d). That is what the letter cited.
What the letter did not say
This matters, because most of the speculation online has filled the gap with the wrong assumptions.
- It did not say our products were contaminated or adulterated.
- It did not dispute our purity figures, our Certificates of Analysis, or our third-party testing.
- It did not name any SARM, nootropic, bioregulator, or PCT compound.
- It was not a recall, a seizure, an injunction, or an order to stop trading.
- It did not allege that anyone had been harmed.
A warning letter is the FDA telling a company, in writing, that it believes something is out of compliance and asking it to fix it. That is the stage this was at, and the fix was in our hands.
What we changed
We discontinued both named products. Semaglutide and Retatrutide are no longer sold by Swiss Chems and will not be returning.
We rewrote our product descriptions. Every listing now describes what a compound is and the mechanism researchers study it for — receptor binding, signalling pathways, molecular targets. None of them describe outcomes in people, because none of these compounds are for people. If you compare an old listing to a current one, that is the difference you will see.
We tightened our review process. Product copy, blog content and social posts now go through a compliance check before publication. The letter was a fair warning about a real problem in how this industry as a whole writes about research compounds, and we would rather be at the careful end of it.
What did not change: our suppliers, our testing programme, our laboratory partners, or the compounds themselves. Batches still go to independent analysts — principally Janoshik Analytical — for HPLC and related validated testing, and lot-specific COAs are still available on request.
Where to find us now
Swiss Chems now operates at SwissChemzLab.com. Same company, same team, same testing partners, same registered business.
We will be straightforward about the move: it was driven by payment processing and platform stability, which in this sector can disappear with very little notice. It was not an attempt to start again quietly. We are the same company at the same registered address, and we would rather tell you that plainly than have you find it out and wonder why we did not.
If you want to check where things stand for yourself, three things are worth doing: read the FDA letter directly, look at our current Independent Test Results, and compare our product pages now against what they used to say.
A note on counterfeits
Whenever a supplier in this sector goes through a visible change, people set up sites and social accounts using the name. Be careful.
- Our only storefront is SwissChemzLab.com.
- Our only support address is support@swisschemzlab.com, and payment details are only ever sent from it. Never pay an account given to you anywhere else.
- Every product carries a scratch panel with a verification code you can check on our Verify Products page.
Frequently asked questions
Is Swiss Chems legit?
Yes. Swiss Chems is operating today at SwissChemzLab.com. In December 2024 we received a warning letter from the FDA about marketing language on two products. We removed those products and rewrote our product descriptions. The letter did not allege that anything we sold was contaminated, mislabeled for purity, or unsafe to handle in a laboratory.
Did the FDA shut Swiss Chems down?
No. A warning letter is not a shutdown order, a seizure, or a recall. It is a written notice that the FDA believes something violates the Federal Food, Drug, and Cosmetic Act, and it asks the company to correct it. We are open and shipping.
What exactly did the FDA letter say?
The letter, dated 10 December 2024, concerned two products: Semaglutide and Retatrutide. The FDA’s position was that although both were labeled for research use only, the way they were described on our website and social media amounted to claims that they treat or prevent disease. Under section 201(g)(1) of the FD&C Act that makes a substance a drug, and an unapproved one violates sections 505(a) and 301(d). The full letter is public on the FDA website.
Was this about product quality or purity?
No. The letter did not question our testing, our purity figures, our laboratories, or our handling. It was entirely about the wording used to describe two products. Our third-party testing programme, our Certificates of Analysis and our Janoshik Analytical reports were never at issue and have continued unchanged.
Which products were affected?
Semaglutide and Retatrutide. Both have been removed from our catalogue. No other product was named in the letter. Our SARMs, peptides, nootropics, bioregulators, PCT compounds and metabolic research compounds were not part of it.
What did Swiss Chems change afterwards?
Three things. We discontinued both named products. We rewrote our product descriptions so they describe mechanism and laboratory context rather than outcomes in people. And we tightened our internal review of anything published on the site or on social media.
Is SwissChemzLab.com the real Swiss Chems?
Yes. Same company, same team, same suppliers, same testing partners. SwissChemzLab.com is our current storefront. If you are ever unsure whether a site claiming to be Swiss Chems is really us, email support@swisschemzlab.com and ask before you pay anyone.
Why did Swiss Chems move to a new domain?
Payment processing and platform stability. Suppliers in this sector regularly lose gateways and services with little notice, and rebuilding on a new domain let us set up cleaner infrastructure. We are not hiding the connection: it is the same company, the same registered address, and the same people you have dealt with before.
Are my previous orders and account affected?
Orders already delivered are unaffected. If you have a question about an older order, email support@swisschemzlab.com with your order number and we will look it up.
Are the products still third-party tested?
Yes. Batches continue to be submitted for independent analysis, principally to Janoshik Analytical, using HPLC and related validated methods. Lot-specific Certificates of Analysis are available on request, and published reports are on our Independent Test Results page.
Do Swiss Chems coupon codes still work?
Codes issued for the previous storefront are not guaranteed to carry over. Current offers are shown on SwissChemzLab.com. We also apply a 10% discount on crypto payments.
Are these products approved for human use?
No, and we do not claim otherwise. Everything we sell is supplied for laboratory research use only. None of it is approved by the FDA for human or veterinary use, none of it is a dietary supplement, and none of it should be consumed. That restriction is the entire point of the correction we made.
The thing we are not going to do
We are not going to tell you the FDA has approved, endorsed or cleared us, because the FDA does not do that for research chemical suppliers and any company telling you otherwise is misleading you.
What we can tell you is specific and checkable: the letter concerned two products, those products are gone, the language that prompted it has been rewritten, and our testing has continued throughout.
Everything we sell is supplied for laboratory research use only. None of it is approved by the FDA for human or veterinary use, none of it is a dietary supplement, and none of it should be consumed.
If you have a question this page has not answered, email support@swisschemzlab.com. We would rather answer it directly than leave you guessing.
Browse the catalogue Independent Test Results Quality Guarantee
Leave a Reply